QinetiQ full steam ahead for year
Defence firm QinetiQ said it expects to perform in line with its expectations for the year, despite challenging markets, as it posted a 16 per cent increase in profit.
Defence firm QinetiQ said it expects to perform in line with its expectations for the year, despite challenging markets, as it posted a 16 per cent increase in profit.
Underlying operating profit rose to £95.3m for the half year ended September 30th 2012 copmared to £81.9m a year earlier. Revenue for the period fell 8% on an organic basis to £685.5m after continuing contract delays in US Services.
The decline in revenue was partially offset by quicker than expected Q-NetTM deliveries, which were originally expected in the second half of the year.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Underlying pre-tax profit rose to £85.8m from £71.2m earlier while underlying net cash from operations, post capex, fell to £95.7m from £157.1m before.
QinetiQ recorded net cash of £21.5m compared to debt of £145.3m previously.
Underlying earnings per share rose to 10.5p from 8.8p before.
Commenting on the results Chief Executive Officer Leo Quinn said: "QinetiQ has delivered a strong first half performance in challenging markets and achieved a position of net cash on its balance sheet - an important milestone in the transformation of the group."
The group, which is implementing its Organic-Plus programme to boost growth, added, "Visibility remains much lower than usual, particularly in the US. Despite this uncertainty, with the benefit of the strong first half performance the Board believes the group as a whole will perform in line with its expectations for the year, absent any material change in customer requirements."
An interim dividend of 1.1p has been offered, up 22% from the same time a year earlier.
CJ
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
What the Employment Rights Bill means for your workplace rights
New workplace reforms are set to give employees new rights to benefits and flexible working
By Marc Shoffman Published
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published